VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 149 filers reported holding VENTYX BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,122,227 | +5.9% | 89,900 | 0.0% | 0.04% | +8.8% |
Q2 2023 | $2,948,720 | -2.1% | 89,900 | 0.0% | 0.03% | -17.1% |
Q1 2023 | $3,011,650 | -72.6% | 89,900 | -73.2% | 0.04% | -80.5% |
Q4 2022 | $10,984,650 | -6.1% | 335,000 | 0.0% | 0.21% | -6.2% |
Q3 2022 | $11,695,000 | +185.5% | 335,000 | 0.0% | 0.22% | +140.9% |
Q2 2022 | $4,097,000 | -9.9% | 335,000 | 0.0% | 0.09% | +69.1% |
Q1 2022 | $4,546,000 | – | 335,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 2,298,833 | $77,010,906 | 42.68% |
Qiming U.S. Ventures Management, LLC | 746,370 | $25,003,395 | 30.26% |
TCG Crossover Management, LLC | 815,724 | $27,326,754 | 5.33% |
ACUTA CAPITAL PARTNERS, LLC | 208,500 | $6,984,750 | 5.15% |
Affinity Asset Advisors, LLC | 260,008 | $8,710,268 | 2.88% |
Avidity Partners Management LP | 1,917,800 | $64,246,300 | 2.13% |
Integral Health Asset Management, LLC | 290,000 | $9,715,000 | 1.96% |
Tri Locum Partners LP | 152,842 | $5,120,207 | 1.56% |
Vivo Capital, LLC | 602,075 | $20,169,513 | 1.40% |
Boxer Capital, LLC | 850,000 | $28,475 | 1.40% |